"This is the longest consecutive period of decline in overdose deaths on record."
Preliminary data from the Centers for Disease Control and Prevention (CDC) indicates that approximately 71,542 people died from drug overdoses in the United States over a 12-month period ending in October 2025. This figure represents a decline from a peak of nearly 113,000 deaths recorded in the 12-month period ending in August 2023.
Overview of the Decline
The decline in overdose deaths is attributed by researchers to multiple factors, including a reported decrease in the potency of illicit fentanyl and improved access to addiction treatment and overdose reversal agents.
- State-Level Variations: While the national trend is downward, some states have experienced significant decreases, while others have seen increases. For example, Alabama, New York, and Virginia saw decreases of 25%–30%. In contrast, Arizona, New Mexico, and North Dakota experienced sharp increases. New York Governor Kathy Hochul noted that opioid deaths in the state have halved since 2022.
- Shifting Drug Types: For the first time in decades, overdoses from stimulants like cocaine and methamphetamines now account for more deaths than overdoses from opioids, according to researcher Lori Ann Post of Northwestern University.
- Demographic Trends: A notable trend is a decline in overdose mortality among young people. Nabarun Dasgupta, a researcher at the University of North Carolina, cited data showing that no one under age 25 has died from a drug overdose in Maine in nearly 12 months. However, Dr. Nora Volkow of the National Institute on Drug Abuse (NIDA) highlighted that high overdose mortality persists among Native American populations, at a rate double the U.S. average, and deaths remain elevated among older Americans and in many Black communities.
The Evolving Synthetic Drug Supply
Researchers note a significant shift in the composition of the street drug supply. It is increasingly composed of synthetic substances made from industrial chemicals, rather than plant-based substances like cocaine and heroin. This new supply is characterized by frequent changes and high variability.
- New Compounds Detected: New synthetic compounds are appearing regularly. Ed Sisco, a research chemist at the National Institute of Standards and Technology, stated that he encounters a substance previously unseen in the United States approximately once a month or every other month. Compounds identified in the supply include:
- Cychlorphine: A synthetic opioid, often described as more potent than fentanyl.
- Nitazenes: A class of synthetic opioids.
- Medetomidine: A sedative.
- Xylazine: A sedative sometimes known as "tranq," which is associated with causing severe skin lesions.
- Additional Adulterants: Other compounds reported include Novocaine and BTPMS, a stabilizer used in plastics manufacturing.
The reasons for adding specific industrial chemicals to the drug supply are not fully understood.
Public Health Implications and Response
The variability and potency of substances in the street drug supply present significant challenges for users and medical professionals.
- Dosage Risks: The changing composition makes it difficult for users to gauge the potency of what they are consuming.
- Treatment Challenges: Some of the new synthetic substances are reported to be resistant to standard overdose reversal treatments like naloxone (Narcan). Medetomidine, in particular, can cause life-threatening withdrawal symptoms if discontinued abruptly, requiring complex medical intervention not typical for fentanyl or xylazine.
- Official Actions:
- The CDC issued a health alert in December 2025 warning of the spread of medetomidine.
- State attorneys general in South Carolina and other states have warned about the spread of cychlorphine.
Researcher Perspectives on Contributing Factors
Researchers have offered multiple perspectives on the dynamics contributing to the decline in mortality.
- Deterrence from Use: Dasgupta suggested that the dangerous and unpredictable nature of the current, heavily adulterated drug supply might be causing some long-term users to reduce or stop their drug use.
- Role of Interventions: Lori Ann Post attributed the decline in opioid deaths to better interventions for opioid use disorder and the widespread availability of reversal agents like naloxone. Beth Meyerson, a harm reduction researcher at the University of Arizona, stated that widespread access to naloxone has been critical.
Recent Incidents
- Baltimore, Maryland: In the summer of 2024, dozens of people were hospitalized due to overdoses linked to a new variety of illicit benzodiazepines. All affected individuals survived.
- Richland County, South Carolina: Coroner Naida Rutherford reported the first detection of cychlorphine in the state during an investigation into an overdose case where standard toxicology tests were initially negative for known substances.